Value Analysis Team (VAT)
VAT Meeting Date: Wednesday, November 26, 2008 - 12:00 - 1:00 p.m. Notes prepared by: Brenda Forbis
Attendees: Ryan Grueber, Kevin Ray, Dr. Faizer, Allan Tallmage, Michelle Reynolds, Susie Wyatt, Amy Tinsley, Theresa Baker, Dr. Stewart, Dr. Choma, Glenn
Absent: Mark Jackson, Lynn McKinney, Dr. Calhoun, Keith Sublette, Dr. Brown
Introduction of New
Review of Minutes Minutes of October 22, 2008 meeting were approved as presented.
I. Product Trial Review Update/Results/Discussion Action
The approved trial of this product in six cases have been completed. Dr.'s Nichols and
Gardner now use talent stent grafts only. Dr. Faizer still has occaisons where he must
use the Zennith graft as not all sizes are currently available in the Talent Stent Graft. Dr.
Talent Stent Graft Faizer will continue to use the Zennith graft until such time as all sizes are available in
Request by Dr. Faizer the Talent graft. Approved
#999 One of the trial cases has been completed. As this product is best used on thin patients, Pended waiting completion of
Mesa Spinal System they are awaiting the appropriate patient to conduct the final trial. last trial case.
Request by Dr. Kuhns
#1467 This product was approved for three trials. Two trials have been completed. Doctor Pended waiting completion of
CopiOs Bone Void Filler response was that the product was okay, but not necessarily better than what we last trial case.
Request by Dr. Crist currently use.
#1856 Dr. Bal has completed the trial of this product. Dr. Bal did indicate that he did approve Denied.
Tri-Lock Bone the product but also stated that he felt it was evenly matched with what we currently use.
Preservation System He stated that he did not believe all of his patients would benefit from this new system.
Request by Dr. Bal His final comment is if what we currently use has a lower price, then we should continue
use of the current product.
#1886 The trial of this product has not started. Pended waiting completion of
Request by UH OR
#1889 The trial of this product has been completed. The product received very high ratings Approved.
Artiss from doctors involved in the trial. They would like to be able to use this product as it is
Request by Burn very benefical to burn patients.
#1660 Trial has not started. Pended waiting completion of
FitMore Hip trial.
1 of 3
Agenda Items Discussion Action (Who? What? Cost/Benefit
II. Old Business
Glenn Berkey is working with physicians to receive and review information on
Baxter Agreement comparison products from Ethicon.
Dr. Choma recommends
approval of a trial case for doctor
Request #1467 that would like to try it. They
CopiOs Bone Void Filler Dr. Choma reported that he had investigated this product further. It consists of bovine should then report back what
Paste collagen and synthetic products and that it is friendly to bones. There is no head to head their findings are with product
Request by Dr. Crist study of Mastergraft vs Copios and both are good products. use.
The Baxter Agreement has been renewed with the reported cost increase. Baxter did
suggent use of a product Gelfoam Plus instead of Surgifoam and Thrombin. The
Baxter Agreement Gelfoam Plus would have an approximate cost of $300.00 which is higher than the cost Will continue to use SurgiFoam
Gelfoam Plus of the current product. and Thrombin.
II. New Business
New Item Requests
Comparison of Ortho Short discussion on the addition of some new orthos. The new packs have been in use
Packs. and proving to be beneficial Approved
Disposable Bipolar Reusable forceps are difficult to keep in supply and difficult to verify insulation coating.
Forceps - two sizes The disposable forceps are currently being used in custom packs. They are single use Cost increase of
Request by UH OR and are currently being used by the ENT and spine doctors as back up. Approved approximately $3,150/yr.
Variax Distal Radius
Request by UH Pended per discussion with $400 per procedure cost
OR/Plastic Surgery Awaiting discussion with Dr. Gainor. doctors. increase.
Variax Hand Solutions
Request by UH This product is similar to Synthes modular currently being used and would be a Pended per discussion with
OR/Plastic Surgery consigment product. doctors. Cost neutral.
This request is pending Dr. Zitsch's approval. This is used in procedures for obstructive
#1990 sleep apnea - genioglossus advancement and stabilization; hyoid and myotomy and
Repose Bone Screw suspension. We currently perform no surgeries of this type. This procedure would be
System another option when CPAP and UPPP or other surgeries fail. Ryan reported that there Pended per discussion with Dr.
Request by UH OR/ Dr. are reimbursement problems. Medicaid/Medicare and Blue Cross do not currently Zitsch and further review of
Chang reimburse for this procedure as they consider it experimental. reimbursement issues.
2 of 3
Finess Sinue Treatment This request is also pending discussion with Dr. Zitsch. Cost would include $2,499 for a
Request by UH OR/ Dr. reusable flexible endoscope and $1,100 for each treatment kit. Current product cost is Pended per discussion with Dr.
Chang $1,600. Zitsch.
This product has an inserter which guides and distracts interbody space and should Less potential trauma to
Lucent PEEK Lumbar allow placement of more appropriately sized interbody spacer. This product has been patient's nerve roots and
Interbody Cages trialed in one case and received excellent reviews from the physician using it. The cost faster for surgeon to
Request by CRH - Dr. is $4,171 each with an estimated usage of 4 per month. Current product cost is $4,271 insert; will not need
Kuhns each. Approved external distractor.
#2024 This product is packaged in blister packs. Current product is packaged in glass vials Approved. Theresa Baker and
Cobalt G, HV High which presents possible glass breakage and contamination of product. This cement is Allan Tallmage will meet with
Contrast cement blue and easily seen so that excess can be removed. There is a possible cost savings doctors to try and consolidate
Request by Dr. Aleto of $20 - $24/each savings over current product. cement products.
Meeting Adjourned: 12:31 p.m.
3 of 3